FDA Investigator: Mohsen Rajabi Abhari
- Mohsen Rajabi Abhari first started conducting FDA inspections in 2016, with the last inspection in 2020. Over that time, Mohsen Rajabi Abhari has conducted 32 inspections at 30 companies across 31 sites.
Get Mohsen Rajabi Abhari's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 PPD Development, Middleton | May 2018
Available Now - $199
Mohsen Rajabi Abhari
Human Drug Form 483
FDA 483 QPS Netherlands B.V., Groningen | 2019
Out-of-stock
Mohsen Rajabi Abhari
Human Drug Form 483
FDA 483 Melbourn Scientific Limited, Royston | 2019
Out-of-stock
Mohsen Rajabi Abhari
Human Drug Form 483
FDA 483 Celerion Inc, Lincoln | 2017
Out-of-stock
Mohsen Rajabi Abhari
Human Drug Form 483
FDA 483 Intertek USA Inc, San Diego | 2017
Out-of-stock
Mohsen Rajabi Abhari
Human Drug Form 483
FDA 483 ICON Laboratory Services, Inc., Whitesboro | 2017
Out-of-stock
Mohsen Rajabi Abhari
Human Drug Form 483
FDA 483 QPS, LLC, Newark | 2016
Out-of-stock
Mohsen Rajabi Abhari
Human Drug Form 483
Co-Investigators (15)
- Himanshu Gupta, FDA Investigator
- Sripal R. Mada, FDA Investigator
- Xikui Chen, FDA Investigator
- Gopa Biswas, FDA Investigator
- Makini Cobourne-Duval, FDA Investigator
- Hasan A. Irier, FDA Investigator
- Li-Hong P. Yeh, FDA Investigator
- Li-Hong Yeh, FDA Investigator
- Jonathan R. Campos, FDA Investigator
- Arindam Dasgupta, FDA Investigator
- Gajendiran Mahadevan, FDA Investigator
- Yiyue Zhang, FDA Investigator
- Lakecha N. Lewis, FDA Investigator
- Nicola M. Fenty-Stewart, FDA Investigator
- Xiaohan Cai, FDA Investigator